Édouard Auclin
0000-0001-7039-4840
Publication & Citation Trends
Publications
0 total
Immune checkpoint inhibitor (ICI) reuse after failure of first-line ICI in patients with metastatic dMMR/MSI gastrointestinal cancers: The INFLATE study.
Cited by 0
Semantic Scholar
Lenvatinib's efficacy in heavily pre-treated metastatic renal cell carcinoma: Insights from a European multicenter study.
Cited by 0
Semantic Scholar
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT).
Cited by 3
Semantic Scholar
A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability. OA
Cited by 12
Semantic Scholar
A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial OA
Cited by 3
Semantic Scholar
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study OA
Cited by 19
Semantic Scholar
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials
Cited by 3
Semantic Scholar
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Cited by 17
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(120)
Lung Cancer Treatments and Mutations
(50)
Cancer Genomics and Diagnostics
(40)
Immunotherapy and Immune Responses
(39)
Inflammatory Biomarkers in Disease Prognosis
(36)
Affiliations
Délégation Paris 5
Inserm
Saint Joseph University
Guy's and St Thomas' NHS Foundation Trust
Université Paris Cité